Xeris Biopharma Holdings Inc (XERS)
Net Receivables
$58.11M
Quarterly · Period ending: · USD
XERS Net Receivables
Latest reported$58.11Mperiod ending
Latest reported$58.11Mperiod ending
XERS Quarterly Net Receivables ($0.00 → $58.11M)
Quarterly net receivables
High-resolution chart · PNG
XERS net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 58,105,000 | |
| 56,295,000 | |
| 51,050,000 | |
| 53,751,000 | |
| 53,048,000 | |
| 46,330,000 | |
| 40,415,000 | |
| 41,138,000 | |
| 42,440,000 | |
| 37,414,000 | |
| 39,197,000 | |
| 45,966,000 | |
| 30,225,000 | |
| 30,860,000 | |
| 30,830,000 | |
| 27,518,000 | |
| 25,756,000 | |
| 23,383,000 | |
| 17,456,000 | |
| 13,561,000 | |
| 12,295,000 | |
| 8,938,000 | |
| 6,875,000 | |
| 12,190,000 | |
| 3,872,000 | |
| 3,258,000 | |
| 4,693,000 | |
| 874,000 | |
| 826,000 | |
| 3,628,000 | |
| 2,869,000 | |
| 1,731,000 | |
| 1,065,000 | |
| 287,000 | |
| 1,199,000 | |
| 0 |